亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Diagnosis and Complication Risk Assessment of Pancreatic Diabetes within Normal Value Ranges of Leuc

總結: This patent can use for daily complication risk Assessment of all diabetic patients and save lifes, suffering from the diabetic complications at all around the world. it is more important method than Hemoglobin A1c. Because all diabetic complications can monitorizing using one marker (procalcitonin) in 24 hours period. New technology of insulin pump system or traditional diabetes mellitus therapy need this invention for proper diabetic complication (retinopathy, nephropathy,neuropathy) treatment

詳細技術說明: This method use rapid or Automatic test device for procalcitonin blood levels

附加資料: Inventor: Chonge Chen | Cleph. Sturt. Keklam | chuxian Wu
Priority Number: CN100572554C
IPC Current: C12Q000168
Assignee Applicant: The Chinese University of Hong Kong
Title: Risk estimution for diabetic to suffer from diabetic renopathy or blood-lipid imbalance | Evaluation diabetes patients suffer from diabetic nephropathy, or dyslipidemia disorder risk of
Usefulness: Risk estimution for diabetic to suffer from diabetic renopathy or blood-lipid imbalance | Evaluation diabetes patients suffer from diabetic nephropathy, or dyslipidemia disorder risk of
Novelty: Risk estimation for diabetic to suffer from diabetic renopathy or blood-lipid imbalance

欲了解更多信息，請點擊這裡